Literature DB >> 19098858

Polymorphism of the IRGM gene might predispose to fistulizing behavior in Crohn's disease.

A Latiano1, O Palmieri, S Cucchiara, M Castro, R D'Incà, G Guariso, B Dallapiccola, M R Valvano, T Latiano, A Andriulli, V Annese.   

Abstract

OBJECTIVES: Recently, genome-wide association analyses have identified single nucleotide polymorphisms in the IRGM gene (rs1000113 and rs4958847) as strong candidate susceptibility factors for Crohn's disease (CD). The aim of our study was to test whether these variants are associated with inflammatory bowel disease (IBD) in adult- and childhood-onset Italian patients.
METHODS: Allele and genotype frequencies of rs1000113 and rs4958847 were determined in 823 CD (265 younger than 19 years at diagnosis), 353 ulcerative colitis (UC) (130 younger than 19 years at diagnosis), and 578 controls. Genotype distributions were examined both within IBD clinical sub-phenotypes and CARD15 genotypes.
RESULTS: rs1000113 and rs4958847 were both associated with adult-onset (P=2 x 10(-4); P=2.5 x 10(-3), respectively) and childhood-onset (P=4 x 10(-4); P=8 x 10(-3), respectively) CD cohorts. Similarly, the genotype frequencies remained significantly different for both variants (adult rs1000113, P=1 x 10(-4); rs4958847, P=1 x 10(-3); pediatric rs1000113, P=2.3 x 10(-4); rs4958847, P=9.6 x 10(-3)). At logistic regression, the rs4958847 polymorphism was associated with fistulizing behavior (P=0.037, OR=1.54, CI=1.02-2.31) and perianal fistulas (P=0.045, OR=1.55, CI=1.01-2.38). Conversely, no association with UC and sub-phenotypes was shown.
CONCLUSIONS: We replicated the previously reported associations between CD and rs1000113 and rs4958847, confirming that IRGM is a susceptibility locus only for CD, either adult- or early-onset in the Italian population; furthermore, we have also shown its influence on specific clinical features (fistulizing disease).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19098858     DOI: 10.1038/ajg.2008.3

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  28 in total

1.  The JAK2 variant rs10758669 in Crohn's disease: altering the intestinal barrier as one mechanism of action.

Authors:  Matthias Prager; Janine Büttner; Verena Haas; Daniel C Baumgart; Andreas Sturm; Martin Zeitz; Carsten Büning
Journal:  Int J Colorectal Dis       Date:  2011-11-09       Impact factor: 2.571

2.  NKX2-3 and IRGM variants are associated with disease susceptibility to IBD in Eastern European patients.

Authors:  Nora Meggyesi; Lajos S Kiss; Magdalena Koszarska; Martin Bortlik; Dana Duricova; Laszlo Lakatos; Tamas Molnar; Martin Leniček; Libor Vítek; Istvan Altorjay; Maria Papp; Zsolt Tulassay; Pal Miheller; Janos Papp; Attila Tordai; Hajnalka Andrikovics; Milan Lukas; Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

3.  Regulation of macrophage motility by Irgm1.

Authors:  Stanley C Henry; Maria Traver; Xiaojou Daniell; Maanasa Indaram; Tim Oliver; Gregory A Taylor
Journal:  J Leukoc Biol       Date:  2009-11-17       Impact factor: 4.962

Review 4.  Surgical strategies in paediatric inflammatory bowel disease.

Authors:  Colin T Baillie; Jennifer A Smith
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

Review 5.  The use of prognostic factors in inflammatory bowel diseases.

Authors:  Thomas Billiet; Marc Ferrante; Gert Van Assche
Journal:  Curr Gastroenterol Rep       Date:  2014-11

Review 6.  Role of genetics in the diagnosis and prognosis of Crohn's disease.

Authors:  Epameinondas V Tsianos; Konstantinos H Katsanos; Vasileios E Tsianos
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

Review 7.  Genetic variation in IBD: progress, clues to pathogenesis and possible clinical utility.

Authors:  Byong Duk Ye; Dermot P B McGovern
Journal:  Expert Rev Clin Immunol       Date:  2016-06-15       Impact factor: 4.473

Review 8.  Human IRGM gene "to be or not to be".

Authors:  Cemaletin Bekpen; Ramnik J Xavier; Evan E Eichler
Journal:  Semin Immunopathol       Date:  2010-08-25       Impact factor: 9.623

Review 9.  Links between autophagy, innate immunity, inflammation and Crohn's disease.

Authors:  Vojo Deretic
Journal:  Dig Dis       Date:  2009-09-24       Impact factor: 2.404

Review 10.  Interferon-Inducible GTPases in Host Resistance, Inflammation and Disease.

Authors:  Danielle Pilla-Moffett; Matthew F Barber; Gregory A Taylor; Jörn Coers
Journal:  J Mol Biol       Date:  2016-05-12       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.